4th Circ. Weighs DEA Power To Classify HHC Schedule I
A Fourth Circuit panel Friday appeared skeptical of the rationale the U.S. Drug Enforcement Administration used to justify designating hexahydrocannabinol, or HHC, a psychoactive compound synthesized from hemp extracts, as a...To view the full article, register now.
Already a subscriber? Click here to view full article